Back to search

Article

Voriconazole Adjustment for Liver Dysfunction (VALID): From Population Pharmacokinetic Model to the Real-World

2025-01-01

Abstract excerpt

<title>Abstract</title> <p>Objective Liver dysfunction affects drug metabolism, including voriconazole, used for treating fungal infections. This study evaluated the effectiveness and safety of a voriconazole dosing regimen adjusted for liver dysfunction (VALID) compared to standard dosing. Methods The study included liver dysfunction patients hospitalized between January 2020 and December 2023. Patients were d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22659b1e-9dc0-51cd-9c1b-eb9f5eea0f7d
DOI
10.21203/rs.3.rs-5720035/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Voriconazole Adjustment for Liver Dysfunction (VALID): From Population Pharmacokinetic Model to the Real-WorldDOI 10.21203/rs.3.rs-5720035/v1
Genetic and clinical predictors of voriconazole pharmacokinetics and hepatotoxicity: focused on CYP2C19 normal and intermediate metabolizers.Semantic proximity
Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysisSemantic proximity
An Interpretable PK-Informed Hybrid Model for Voriconazole Exposure Prediction: Roles of CYP2C19 Genotype and Inflammation.Semantic proximity
Pharmacogenomic Profiling of Voriconazole Enables Predicting Its Toxicity in Pediatric Leukemia and Hematopoietic Stem Cell Transplant Recipients-A Prospective Study From North India.Semantic proximity
Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.Semantic proximity
Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.Semantic proximity
CYP2C19-Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients.Semantic proximity
Impact of cytochrome P450 2C19 polymorphisms on the clinical efficacy and safety of voriconazole: an update systematic review and meta-analysis.Semantic proximity
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing.Semantic proximity
Population Pharmacokinetics and Factors Influencing Trough Concentration of Voriconazole in Children with Hematological MalignanciesSemantic proximity
Dual toxicity of voriconazole in a CYP2C19 poor metabolizer: A case analysis of Life-threatening neutropenia and hepatocellular injurySemantic proximity
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling.Semantic proximity
Select a neighboring publication to make it the new centre.